RE: Shaping up nicely23 Nov 2025 10:15
Soupdragon, you're simply making excuses for more failure. Here's where we are:
* No partnership after the 'key' EMA ODD approval target was hit back in May. That should have been a reward point for shareholders. Instead, the price fell back as it immediately turned into a fundraise opportunity and the can was kicked down the road towards needing FDA ODD approval before any partnership could be announced.
* Here and now. No FDA approval after 90 days. Instead we get a another fundraiser just before we get the 'request for info' RNS which is now (according to you) a new opportunity for things to remain open ended until the board can be bothered to muster a response.
In all this time (nearly 2 years), absolutely zero evidence of any potential partnership (other than hearsay). It's just the shareholders taking all the risk as usual.
I was foolishly starting to think that there was light at the of the tunnel but if they can't even mobilise to get a decision before Xmas then I can't see how they will ever get a worthwhile deal for the long suffering shareholders .